Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Collaborative Health Research Projects

McGill University

$143,325.00

Novel Delivery System for High Dose Rate Intensity Modulated Brachytherapy with Yb-169 as a Radiation Source

EF 2018-19

Résumé
Radiotherapy is an effective and safe treatment for cancer. Approximately 50% of cancer*patients benefit from this treatment, that is, close to 100,000 Canadians with cancer each*year. Brachytherapy, is a form of radiotherapy where radioactive sources are placed inside or*near the tumours using thin, hollow tubes (catheters) implanted for a short period of time,*giving a high radiation dose to the tumour while maintaining a low dose to surrounding healthy tissues. However, dose distribution in conventional brachytherapy is identical in all directions resulting in dose spillage to radiation sensitive*healthy tissues. This proposal aims to develop a novel radiation delivery system that will*manipulate the radiation dose to conform to the shape of a tumour by incorporating radiation*shields inside the implanted hollow tubes, i.e. the delivery system will modulate the intensity*of the emitted radiation from the brachytherapy source. The shields can rotate during the*treatment, direct the radiation towards the tumour and away from healthy tissues. Developing and making intensity*modulated brachytherapy clinically available, will significantly improve the potential of*brachytherapy with reduced toxicity will increase the cure rates and improve the quality of life*for Canadians with prostate, breast, cervical, uterine, vaginal, vulvar, head & neck and*oesophageal cancers. In addition, this proposal will offer undergraduate and graduate student*to work in a multidisciplinary environment with radiation oncology, radiation physics, biology,*computing and engineering.
Programme
Collaborative Health Research Projects
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
523394-2018
Name nom
AbbasinejadEnger, Shirin
Department département
Medical Physics Unit
Organization id
61
Institution établissement
McGill University
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2018
Competition year année de concours
2018
Award amount
143325
Program id
CHRPJ
Program name en
Collaborative Health Research Projects
Program name fr
Projets de recherche concertée sur la santé
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
360
Committee name en
Collaborative Health Research Projects Selection Panel
Committee name fr
Comité de sélection de projets de recherche concertée sur la santé
Area of application code
9999
Area of application group en
Not available
Area of application group fr
Non disponible
Area of application en
Not available
Area of application fr
Non disponible
Research subject code
9999
Research subject group en
Not available
Research subject group fr
Non disponible
Research subject en
Not available
Research subject fr
Non disponible
Partie
1
Nb partie
1
Application title
Novel Delivery System for High Dose Rate Intensity Modulated Brachytherapy with Yb-169 as a Radiation Source
Keyword
NSERC
Application summary
Radiotherapy is an effective and safe treatment for cancer. Approximately 50% of cancer*patients benefit from this treatment, that is, close to 100,000 Canadians with cancer each*year. Brachytherapy, is a form of radiotherapy where radioactive sources are placed inside or*near the tumours using thin, hollow tubes (catheters) implanted for a short period of time,*giving a high radiation dose to the tumour while maintaining a low dose to surrounding healthy tissues. However, dose distribution in conventional brachytherapy is identical in all directions resulting in dose spillage to radiation sensitive*healthy tissues. This proposal aims to develop a novel radiation delivery system that will*manipulate the radiation dose to conform to the shape of a tumour by incorporating radiation*shields inside the implanted hollow tubes, i.e. the delivery system will modulate the intensity*of the emitted radiation from the brachytherapy source. The shields can rotate during the*treatment, direct the radiation towards the tumour and away from healthy tissues. Developing and making intensity*modulated brachytherapy clinically available, will significantly improve the potential of*brachytherapy with reduced toxicity will increase the cure rates and improve the quality of life*for Canadians with prostate, breast, cervical, uterine, vaginal, vulvar, head & neck and*oesophageal cancers. In addition, this proposal will offer undergraduate and graduate student*to work in a multidisciplinary environment with radiation oncology, radiation physics, biology,*computing and engineering.